|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149.40 INR | +1.46% |
|
+0.40% | +81.64% |
| 05-22 | IOL Chemicals and Pharmaceuticals Limited, Q4 2026 Earnings Call, May 22, 2026 | |
| 05-20 | IOL Chemicals and Pharmaceuticals March-quarter consol profit 531.6 million rupees | RE |
| Market Cap | 43.22B 446M 393M 365M 335M 629M 640M 4.36B 1.7B 21.08B 1.68B 1.64B 73.14B | P/E 2026 |
15.5x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 43.22B 446M 393M 365M 335M 629M 640M 4.36B 1.7B 21.08B 1.68B 1.64B 73.14B | EV / Sales 2026 |
0.92x | EV / Sales 2027 * | 1.63x |
| Free-Float |
33.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IOL Chemicals and Pharmaceuticals Limited
| 1 day | +1.46% | ||
| 1 week | +0.40% | ||
| Current month | +2.89% | ||
| 1 month | +14.09% | ||
| 3 months | +67.87% | ||
| 6 months | +113.52% | ||
| Current year | +81.64% |
| 1 week | 143.8 | 161.55 | |
| 1 month | 132.1 | 179.65 | |
| Current year | 67.14 | 179.65 | |
| 1 year | 67.14 | 179.65 | |
| 3 years | 57.51 | 179.65 | |
| 5 years | 54.44 | 179.65 | |
| 10 years | 8.4 | 179.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 14/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Varinder Gupta
CHM | Chairman | 63 | 01/09/2007 |
Vikas Gupta
BRD | Director/Board Member | 34 | 29/05/2015 |
| Chairman | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.46% | +0.40% | +55.72% | +102.30% | 446M | ||
| +1.34% | +2.26% | +49.70% | +162.51% | 1,057B | ||
| +1.33% | +3.79% | +54.89% | +53.51% | 624B | ||
| +0.98% | +2.17% | +36.25% | +81.59% | 454B | ||
| +1.67% | +6.64% | +34.44% | +30.31% | 341B | ||
| -0.53% | +1.97% | +36.28% | +40.37% | 297B | ||
| +0.26% | +1.24% | +16.91% | +18.27% | 262B | ||
| +1.20% | -1.79% | -27.52% | -41.09% | 215B | ||
| +1.88% | +3.55% | +22.93% | +61.12% | 201B | ||
| -0.19% | -3.08% | +14.96% | +67.58% | 162B | ||
| Average | +0.97% | -0.12% | +29.46% | +57.65% | 361.44B | |
| Weighted average by Cap. | +1.08% | +1.97% | +36.34% | +78.53% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 23.04B 238M 209M 194M 179M 335M 341M 2.32B 906M 11.24B 893M 874M 38.98B | 26.48B 273M 241M 223M 206M 385M 392M 2.67B 1.04B 12.92B 1.03B 1B 44.82B |
| Net income | 1.3B 13.38M 11.77M 10.93M 10.06M 18.86M 19.2M 131M 51M 632M 50.24M 49.15M 2.19B | - |
| Net Debt | - | - |
Employees
2,891
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | ₹149.40 | +1.46% | 156,643 |
| 23/07/26 | ₹147.25 | -0.61% | 134,273 |
| 22/07/26 | ₹148.15 | -1.89% | 102,905 |
| 21/07/26 | ₹151.00 | -2.83% | 131,783 |
| 20/07/26 | ₹155.40 | +4.44% | 389,466 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
147.25INR
Average target price
150.00INR
Spread / Average Target
+1.87%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IOLCP Stock
Select your edition
All financial news and data tailored to specific country editions

















